Drug Shortage Report for JAMP-TOBRAMYCIN
Report ID | 4845 |
Drug Identification Number | 02420287 |
Brand name | JAMP-TOBRAMYCIN |
Common or Proper name | Tobramycin |
Company Name | JAMP PHARMA CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 40MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10x2 |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-09-21 |
Estimated end date | 2020-12-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-12-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-30 | English | Compare |
v2 | 2017-03-30 | French | Compare |
v3 | 2017-04-12 | English | Compare |
v4 | 2017-04-12 | French | Compare |
v5 | 2017-06-09 | English | Compare |
v6 | 2017-06-09 | French | Compare |
v7 | 2017-11-21 | English | Compare |
v8 | 2017-11-21 | French | Compare |
v9 | 2018-10-15 | English | Compare |
v10 | 2018-10-15 | French | Compare |
v11 | 2018-12-19 | English | Compare |
v12 | 2018-12-19 | French | Compare |
Showing 1 to 12 of 12